Brian N. Cunningham, MD has been extensively involved in Bay City Capital’s investment activities since he joined The Pritzker Organization in 2004. Dr. Cunningham has served in various operational roles with a number of Bay City Capital portfolio companies, most notably Madrigal Pharmaceuticals. Dr. Cunningham has been instrumental in the execution of numerous collaborations and licensing deals, provided oversight of portfolio company financial functions including budgetary responsibilities, and advised on clinical development strategies. Prior to joining The Pritzker Organization, Dr. Cunningham was a Consultant with L.E.K. Consulting, focusing in the biopharmaceutical and medical device sectors. Prior to joining L.E.K., Dr. Cunningham was a Research Fellow at the Cleveland Clinic Foundation in the Department of Plastic and Reconstructive Surgery. After matriculating in a combined BS/MD program, he received his medical degree with honors in 2001 from Northeastern Ohio University College of Medicine.